Wednesday, April 28, 2021

Boundless Bio Picks Up $105M

San Diego-based Boundless Bio, a company developing therapeutics for treating cancer, has raised $105M in its Series B funding, the company said this morning. According to the company, the funding was led by Nextech invest and RA Capital Management, and also included new investors Fidelity Management & Research Company LLC, Redmile Group, Wellington

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.